Evidence map›Paper›PMID 41152785›Full record

ArticleBMC infectious diseases2025

Post-pandemic resurgence of respiratory virus infections: age and department-specific patterns in a Chinese tertiary hospital (2020-2024).

Shan Hong, Maoshu Zhu, Yanqian Huang, Linlin Chen, Dandan Han, Wenliu Qiu, Shujing Li, Linghui Ding, Heping Zheng, Feng Guo and 6 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Shan Hong *The Fifth Hospital of Xiamen, Xiamen, Fujian, 361101, China.
Maoshu Zhu *The Fifth Hospital of Xiamen, Xiamen, Fujian, 361101, China.
Yanqian HuangCommunity Health Service Center, Maxiang Street, Xiang'an District, Xiamen, Fujian, 361101, China.
Linlin ChenThe Fifth Hospital of Xiamen, Xiamen, Fujian, 361101, China.
Dandan HanThe Fifth Hospital of Xiamen, Xiamen, Fujian, 361101, China.
Wenliu QiuThe Fifth Hospital of Xiamen, Xiamen, Fujian, 361101, China.
Shujing LiThe Fifth Hospital of Xiamen, Xiamen, Fujian, 361101, China.
Linghui DingThe Fifth Hospital of Xiamen, Xiamen, Fujian, 361101, China.
Heping ZhengThe Fifth Hospital of Xiamen, Xiamen, Fujian, 361101, China.
Feng GuoXiamen Xiang'an District Center for Disease Control and Prevention, Xiamen, Fujian, 361101, China.
Jun MiThe Fifth Hospital of Xiamen, Xiamen, Fujian, 361101, China.
Xiuli LiThe Fifth Hospital of Xiamen, Xiamen, Fujian, 361101, China.
Jie ChenCommunity Health Service Center, Maxiang Street, Xiang'an District, Xiamen, Fujian, 361101, China.
Dongjie LiCommunity Health Service Center, Maxiang Street, Xiang'an District, Xiamen, Fujian, 361101, China.
Liangneng ZouThe Fifth Hospital of Xiamen, Xiamen, Fujian, 361101, China. 15860703727@163.com.
Yanli WeiThe Fifth Hospital of Xiamen, Xiamen, Fujian, 361101, China. swylxpy@163.com.

Funding

Fujian Province Science and Technology Plan 2022D032Fujian Province Science and Technology Plan Project 2022D030Natural Science Foundation of Xiamen China 3502Z20227302Xiamen Medical and Health Guidance Project 3502Z20244ZD1300
6 · The paper itself

Abstract

backgroundThe Coronavirus Disease 2019 (COVID-19) pandemic dramatically altered the epidemiology of respiratory viral infections worldwide, yet comprehensive post-pandemic recovery dynamics remain poorly understood, particularly in China. This study analyzed patterns of respiratory virus infections in a Chinese tertiary hospital setting across the pandemic and post-pandemic period.

methodsWe conducted a retrospective analysis of 9,237 patients who are tested for 13 respiratory viruses across multiple age groups and hospital departments at Xiamen Fifth Hospital in Southeatern China between January 2020 and early 2024. Advanced statistical approaches including seasonal Mann-Kendall trend analyses, and multivariate logistic regression were employed to identify temporal patterns and demographic risk factors.

resultsChildren comprised 57.2% of patients, adults 30.2%, and elderly 12.6%. Age-specific viral patterns showed human rhinovirus (HRV) and Mycoplasma pneumoniae (MP) are two highest predominating in children, while influenza A virus (IAV) displayed an inverse age relationship with higher positivity in elderly patients. Seasonal Mann-Kendall analysis revealed significant increasing trends for IAV across all age groups and MP showing extraordinary temporal surges during 2023–2024, indicating substantial rebound effects following initial pandemic suppression. Co-infection patterns increased with advancing age, reflecting heightened vulnerability in older populations. Importantly, department-specific analysis revealed that viral distribution patterns extended beyond simple age demographics, with children-dominant departments showing strong associations with RSV and Mycoplasma infections, while adult-focused departments demonstrated elevated risks for influenza viruses.

conclusionsThis analysis demonstrates heterogeneous post-pandemic respiratory virus recovery patterns that vary significantly across demographic and clinical settings. Department-specific analysis revealed that viral distribution extended beyond simple age demographics.These findings support implementing specific clinical protocols including: (1) enhanced multiplex testing prioritization for pediatric populations given their highest co-infection rates, (2) prioritized MP and RSV testing in pediatric departments, (3) enhanced IAV surveillance in elderly populations and (4) department-based patient cohorting strategies. Healthcare systems should establish routine seasonal surveillance calibrated to local subtropical patterns and prepare resource allocation for anticipated pathogen surges. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Respiratory Tract InfectionsVirus DiseasesAdolescentAdultAgedAged, 80 and overAge FactorsChildChild, PreschoolChinaCOVID-19East Asian PeopleFemaleHumansInfantInfant, NewbornAge groupsCOVID-19 pandemicHospital departmentsInfection controlInfluenzaMycoplasma pneumoniaePost-pandemic surveillanceRespiratory virusesSeasonalitySoutheastern ChinaViral co-infection

Identifiers

PMID41152785
PMCPMC12570771

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.